VTRS Stock: Price, Earnings History and SEC Filings
Viatris Inc. (VTRS) last traded at $19.04, down 0.86% on the latest session and up 7.4% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $0.69 against an analyst estimate of $0.62, a beat of 11.3%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
VTRS earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 6, 2026 | $0.69 | $0.62 | +11.29% |
| Mar 2026 | May 7, 2026 | $0.59 | $0.52 | +13.46% |
| Dec 2025 | Feb 26, 2026 | $0.57 | $0.52 | +9.62% |
| Sep 2025 | Nov 6, 2025 | $0.67 | $0.63 | +6.35% |
VTRS beat the analyst EPS estimate in 4 of its last 4 reported quarters. Source: Nasdaq.
How VTRS reacts to earnings
Across its last 8 earnings releases, VTRS moved 8.7% on average the next session, in either direction. It rose after 4 of 8 reports.
| Report date | Released | Next-session move |
|---|---|---|
| 2026-08-06 | Before open | -7.71% |
| 2026-05-07 | Before open | +9.03% |
| 2026-02-26 | Before open | -5.16% |
| 2025-11-06 | Before open | -5.95% |
| 2025-08-07 | Before open | +7.31% |
| 2025-05-08 | Before open | +5.70% |
| 2025-02-27 | Before open | -15.21% |
| 2024-11-07 | Before open | +13.52% |
Based on the dates of earnings-release 8-K filings (SEC EDGAR) and daily closing prices (Yahoo Finance). Past reactions do not predict future ones.
VTRS financial history
| Fiscal year | Revenue | Net income | Free cash flow | Net margin | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | $14.3B | – | $1.9B | – | $-3.00 |
| 2024 | $14.7B | – | $2.0B | – | $-0.53 |
| 2023 | $15.4B | – | $2.5B | – | $0.05 |
| 2022 | $16.2B | – | $2.6B | – | $1.71 |
| 2021 | $17.8B | – | $2.6B | – | $-1.05 |
| 2020 | $11.8B | – | $989M | – | $-1.11 |
| 2019 | $11.4B | – | $1.6B | – | $0.03 |
| 2018 | $11.3B | – | $2.1B | – | $0.68 |
Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.
Latest SEC filings for VTRS
- 8-K · Oct 8, 2026Material agreement, Other events, Financial statements and exhibits
- 10-Q · Aug 6, 2026
- 8-K · Aug 6, 2026Results of operations, Other events, Financial statements and exhibits
- 8-K · Jul 1, 2026Material agreement, New financial obligation, Financial statements and exhibits
- 8-K · Jun 18, 2026Material agreement, New financial obligation, Financial statements and exhibits
- 8-K · Jun 15, 2026Other events, Financial statements and exhibits
- 424B5 · Jun 15, 2026
- 424B5 · Jun 12, 2026
- 8-K · May 15, 2026Shareholder vote
- 10-Q · May 7, 2026
Insider filing activity
VTRS insiders filed 3 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
VTRS news
- 4 Medical Stocks With a Healthy Shot at Q3 Earnings BeatsOct 30, 2026 · finance.yahoo.com
- Viatris Announces Commencement of Tender Offer to Acquire Pacira BioSciences, Inc.Oct 30, 2026 · finance.yahoo.com
- Why Did MA, LNG, VTRS Stocks Surge To 52-Week Highs?Oct 30, 2026 · stocktwits.com
- RYZUMVI Approval Could Be A Key Test For Viatris Stock (VTRS)Oct 29, 2026 · finance.yahoo.com
- Viatris (VTRS) Expected to Beat Earnings Estimates: Should You Buy?Oct 29, 2026 · finance.yahoo.com
- 1 stock under $50 worth investigating and 2 we ignoreOct 29, 2026 · finance.yahoo.com
- 1 cash-producing stock with competitive advantages and 2 we brush offOct 29, 2026 · finance.yahoo.com
- Viatris (VTRS) Wins FDA Approval For RYZUMVI In Adult PresbyopiaOct 28, 2026 · finance.yahoo.com
About Viatris Inc.
Viatris Inc. (VTRS) is a US-listed public company on Nasdaq. The SEC classifies its business as Pharmaceutical Preparations. It is incorporated in DE. Its fiscal year ends in December.